Goldman Sachs reiterated its Buy rating on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shares with a steady price target of $78.00. The firm's analyst highlighted Ultragenyx's fourth-quarter total ...

In the realm of hyper-competitive private equity, investment banking, and strategy consulting, fewer than 1% of applicants ever hear “Yes” from firms like KKR, McKinsey, or Goldman Sachs. Many believe ...

Banco Santander (Brasil) (NYSE:BSBR – Get Free Report) was upgraded by stock analysts at The Goldman Sachs Group from a “sell” rating to a “neutral” rating in a note issued to investors on Wednesday, ...

Fintel reports that on February 11, 2025, Goldman Sachs downgraded their outlook for Dynavax Technologies (NasdaqGS:DVAX) ...

Ashok Leyland shares, flagship of Hinduja Group, gained 2.6% in early trade on Thursday, after the company recorded a 31% ...

Another potential implication is a stronger dollar, which would further hurt S&P 500 earnings because the companies get 28% ...

The majority of dividend-paying stocks distribute payouts on a quarterly basis, or every three months. However, companies ...

Leading commercial lenders are either halting or limiting sales of gold bars, prompted by the rapid depletion of the precious ...

Following Q3FY25 results, Eicher Motors’ stock dropped nearly 7% as Goldman Sachs lowered its target price. The company reported an 18% increase in net profit to ₹1,170 crore and revenue surged by 19% ...

We recently published a list of 10 Worst Performing Bank Stocks in 2024. In this article, we are going to take a look at ...

Eicher Motors stock price fell nearly 7% in early trade despite reporting a 18% year-on-year rise in consolidated net profit.

Eicher Motors shares tumble nearly seven per cent post Q3 results as Goldman Sachs slashes target price, citing higher ...